drugset

drugset / Trial / NCT00444834

A Study of Controlled-Release Carvedilol Compared to Immediate-Release Carvedilol in Patients With Primary Hypertension

NCT00444834 ↗

Phase 2 Terminated 14 enrolled Egalet Ltd

RandomizedCrossoverQuadruple-blindTreatment

Summary

The purpose of this study is to compare the efficacy of the Egalet® controlled release formulation to an immediate release Carvedilol tablet.

Timeline

Start: 2007-04
Primary completion: 2007-05
Completion: 2007-05

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Carvedilol	Other / unclassified	50 mg	—

Indications